1228.HK
Price:
$2.37
Market Cap:
$914.49M
CANbridge Pharmaceuticals Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide. The company offers Hunterase, an enzyme replacement therapy for the treatment of Hunter syndrome; NERLYNX (Neratinlib), a potent irreversible tyrosine kinase inhibitor for HER2-positive breast cancer; and Caphosol Mouth Rinse for temporary and persistent dryness of the mouth and throat. It also engages in the development of CAN008, an artificially engineered antibody-like fully human fusion protein for the treatment of glioblastoma multiforme; CAN108, an orally absorbed reversible inhibitor of the ileal bil...[Read more]
Industry
Biotechnology
IPO Date
2021-12-10
Stock Exchange
HKSE
Ticker
1228.HK
According to CANbridge Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is 30.81%. This represents a change of 361.74% compared to the average of 6.67% of the last 4 quarters.
The mean historical ROE of CANbridge Pharmaceuticals Inc. over the last ten years is 133.97%. The current 30.81% ROE has changed -77.00% with respect to the historical average. Over the past ten years (40 quarters), 1228.HK's ROE was at its highest in in the September 2023 quarter at 201.92%. The ROE was at its lowest in in the March 2023 quarter at -88.37%.
Average
133.97%
Median
35.22%
Minimum
-156.69%
Maximum
952.14%
Discovering the peaks and valleys of CANbridge Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 120.54%
Maximum Annual ROE = 952.14%
Minimum Annual Increase = -707.66%
Minimum Annual ROE = -156.69%
| Year | ROE | Change |
|---|---|---|
| 2024 | 93.28% | -90.20% |
| 2023 | 952.14% | -707.66% |
| 2022 | -156.69% | 0.88% |
| 2021 | -155.32% | -420.52% |
| 2020 | 48.46% | 120.54% |
The current ROE of CANbridge Pharmaceuticals Inc. (1228.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
296.24%
5-year avg
156.37%
10-year avg
133.97%
CANbridge Pharmaceuticals Inc.’s ROE is greater than Kintor Pharmaceutical Limited (0%), less than Uni-Bio Science Group Limited (25.79%), less than Sirnaomics Ltd. (412.36%), greater than China Biotech Services Holdings Limited (-59.63%), greater than ClouDr Group Limited (-78.61%), less than Wenzhou Kangning Hospital Co., Ltd. (4.18%), less than Hospital Corporation of China Limited (31.63%), greater than Transcenta Holding Limited (-37.95%), less than Beijing Biostar Pharms Co Ltd (0%), greater than Suzhou Basecare Medical Corporation Limited (-21.93%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $869.93M | |
| 25.79% | $679.83M | |
| 412.36% | $721.56M | |
| -59.63% | $905.66M | |
| -78.61% | $697.13M | |
| 4.18% | $832.91M | |
| 31.63% | $818.96M | |
| -37.95% | $1.15B | |
| 0% | $652.33M | |
| -21.93% | $623.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CANbridge Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CANbridge Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CANbridge Pharmaceuticals Inc.'s ROE?
How is the ROE calculated for CANbridge Pharmaceuticals Inc. (1228.HK)?
What is the highest ROE for CANbridge Pharmaceuticals Inc. (1228.HK)?
What is the 3-year average ROE for CANbridge Pharmaceuticals Inc. (1228.HK)?
What is the 5-year average ROE for CANbridge Pharmaceuticals Inc. (1228.HK)?
How does the current ROE for CANbridge Pharmaceuticals Inc. (1228.HK) compare to its historical average?